- IBDEI0RL ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,12421,1,4,0)
- ;;=4^E11.311
- ;;^UTILITY(U,$J,358.3,12421,2)
- ;;=^5002632
- ;;^UTILITY(U,$J,358.3,12422,0)
- ;;=E11.319^^49^600^22
- ;;^UTILITY(U,$J,358.3,12422,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12422,1,3,0)
- ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,12422,1,4,0)
- ;;=4^E11.319
- ;;^UTILITY(U,$J,358.3,12422,2)
- ;;=^5002633
- ;;^UTILITY(U,$J,358.3,12423,0)
- ;;=E11.40^^49^600^11
- ;;^UTILITY(U,$J,358.3,12423,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12423,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
- ;;^UTILITY(U,$J,358.3,12423,1,4,0)
- ;;=4^E11.40
- ;;^UTILITY(U,$J,358.3,12423,2)
- ;;=^5002644
- ;;^UTILITY(U,$J,358.3,12424,0)
- ;;=E11.41^^49^600^10
- ;;^UTILITY(U,$J,358.3,12424,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12424,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
- ;;^UTILITY(U,$J,358.3,12424,1,4,0)
- ;;=4^E11.41
- ;;^UTILITY(U,$J,358.3,12424,2)
- ;;=^5002645
- ;;^UTILITY(U,$J,358.3,12425,0)
- ;;=E11.42^^49^600^14
- ;;^UTILITY(U,$J,358.3,12425,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12425,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
- ;;^UTILITY(U,$J,358.3,12425,1,4,0)
- ;;=4^E11.42
- ;;^UTILITY(U,$J,358.3,12425,2)
- ;;=^5002646
- ;;^UTILITY(U,$J,358.3,12426,0)
- ;;=E11.43^^49^600^8
- ;;^UTILITY(U,$J,358.3,12426,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12426,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
- ;;^UTILITY(U,$J,358.3,12426,1,4,0)
- ;;=4^E11.43
- ;;^UTILITY(U,$J,358.3,12426,2)
- ;;=^5002647
- ;;^UTILITY(U,$J,358.3,12427,0)
- ;;=E11.51^^49^600^12
- ;;^UTILITY(U,$J,358.3,12427,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12427,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
- ;;^UTILITY(U,$J,358.3,12427,1,4,0)
- ;;=4^E11.51
- ;;^UTILITY(U,$J,358.3,12427,2)
- ;;=^5002650
- ;;^UTILITY(U,$J,358.3,12428,0)
- ;;=E11.52^^49^600^13
- ;;^UTILITY(U,$J,358.3,12428,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12428,1,3,0)
- ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
- ;;^UTILITY(U,$J,358.3,12428,1,4,0)
- ;;=4^E11.52
- ;;^UTILITY(U,$J,358.3,12428,2)
- ;;=^5002651
- ;;^UTILITY(U,$J,358.3,12429,0)
- ;;=E11.621^^49^600^15
- ;;^UTILITY(U,$J,358.3,12429,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12429,1,3,0)
- ;;=3^DM Type 2 w/ Foot Ulcer
- ;;^UTILITY(U,$J,358.3,12429,1,4,0)
- ;;=4^E11.621
- ;;^UTILITY(U,$J,358.3,12429,2)
- ;;=^5002656
- ;;^UTILITY(U,$J,358.3,12430,0)
- ;;=E11.641^^49^600^17
- ;;^UTILITY(U,$J,358.3,12430,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12430,1,3,0)
- ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
- ;;^UTILITY(U,$J,358.3,12430,1,4,0)
- ;;=4^E11.641
- ;;^UTILITY(U,$J,358.3,12430,2)
- ;;=^5002661
- ;;^UTILITY(U,$J,358.3,12431,0)
- ;;=E11.649^^49^600^18
- ;;^UTILITY(U,$J,358.3,12431,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12431,1,3,0)
- ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
- ;;^UTILITY(U,$J,358.3,12431,1,4,0)
- ;;=4^E11.649
- ;;^UTILITY(U,$J,358.3,12431,2)
- ;;=^5002662
- ;;^UTILITY(U,$J,358.3,12432,0)
- ;;=E78.01^^49^600^24
- ;;^UTILITY(U,$J,358.3,12432,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12432,1,3,0)
- ;;=3^Familial Hypercholesterolemia
- ;;^UTILITY(U,$J,358.3,12432,1,4,0)
- ;;=4^E78.01
- ;;^UTILITY(U,$J,358.3,12432,2)
- ;;=^7570555
- ;;^UTILITY(U,$J,358.3,12433,0)
- ;;=E78.00^^49^600^33
- ;;^UTILITY(U,$J,358.3,12433,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,12433,1,3,0)
- ;;=3^Pure Hypercholesterolemia,Unspec
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RL 3777 printed Feb 18, 2025@23:20:46 Page 2
- IBDEI0RL ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,12421,1,4,0)
- +2 ;;=4^E11.311
- +3 ;;^UTILITY(U,$J,358.3,12421,2)
- +4 ;;=^5002632
- +5 ;;^UTILITY(U,$J,358.3,12422,0)
- +6 ;;=E11.319^^49^600^22
- +7 ;;^UTILITY(U,$J,358.3,12422,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,12422,1,3,0)
- +10 ;;=3^DM Type 2 w/ Unspec Diabetic Retinopathy w/o Macular Edema
- +11 ;;^UTILITY(U,$J,358.3,12422,1,4,0)
- +12 ;;=4^E11.319
- +13 ;;^UTILITY(U,$J,358.3,12422,2)
- +14 ;;=^5002633
- +15 ;;^UTILITY(U,$J,358.3,12423,0)
- +16 ;;=E11.40^^49^600^11
- +17 ;;^UTILITY(U,$J,358.3,12423,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,12423,1,3,0)
- +20 ;;=3^DM Type 2 w/ Diabetic Neuropathy,Unspec
- +21 ;;^UTILITY(U,$J,358.3,12423,1,4,0)
- +22 ;;=4^E11.40
- +23 ;;^UTILITY(U,$J,358.3,12423,2)
- +24 ;;=^5002644
- +25 ;;^UTILITY(U,$J,358.3,12424,0)
- +26 ;;=E11.41^^49^600^10
- +27 ;;^UTILITY(U,$J,358.3,12424,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,12424,1,3,0)
- +30 ;;=3^DM Type 2 w/ Diabetic Mononeuropathy
- +31 ;;^UTILITY(U,$J,358.3,12424,1,4,0)
- +32 ;;=4^E11.41
- +33 ;;^UTILITY(U,$J,358.3,12424,2)
- +34 ;;=^5002645
- +35 ;;^UTILITY(U,$J,358.3,12425,0)
- +36 ;;=E11.42^^49^600^14
- +37 ;;^UTILITY(U,$J,358.3,12425,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,12425,1,3,0)
- +40 ;;=3^DM Type 2 w/ Diabetic Polyneuropathy
- +41 ;;^UTILITY(U,$J,358.3,12425,1,4,0)
- +42 ;;=4^E11.42
- +43 ;;^UTILITY(U,$J,358.3,12425,2)
- +44 ;;=^5002646
- +45 ;;^UTILITY(U,$J,358.3,12426,0)
- +46 ;;=E11.43^^49^600^8
- +47 ;;^UTILITY(U,$J,358.3,12426,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,12426,1,3,0)
- +50 ;;=3^DM Type 2 w/ Diabetic Autonomic Polyneuropathy
- +51 ;;^UTILITY(U,$J,358.3,12426,1,4,0)
- +52 ;;=4^E11.43
- +53 ;;^UTILITY(U,$J,358.3,12426,2)
- +54 ;;=^5002647
- +55 ;;^UTILITY(U,$J,358.3,12427,0)
- +56 ;;=E11.51^^49^600^12
- +57 ;;^UTILITY(U,$J,358.3,12427,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,12427,1,3,0)
- +60 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/o Gangrene
- +61 ;;^UTILITY(U,$J,358.3,12427,1,4,0)
- +62 ;;=4^E11.51
- +63 ;;^UTILITY(U,$J,358.3,12427,2)
- +64 ;;=^5002650
- +65 ;;^UTILITY(U,$J,358.3,12428,0)
- +66 ;;=E11.52^^49^600^13
- +67 ;;^UTILITY(U,$J,358.3,12428,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,12428,1,3,0)
- +70 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
- +71 ;;^UTILITY(U,$J,358.3,12428,1,4,0)
- +72 ;;=4^E11.52
- +73 ;;^UTILITY(U,$J,358.3,12428,2)
- +74 ;;=^5002651
- +75 ;;^UTILITY(U,$J,358.3,12429,0)
- +76 ;;=E11.621^^49^600^15
- +77 ;;^UTILITY(U,$J,358.3,12429,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,12429,1,3,0)
- +80 ;;=3^DM Type 2 w/ Foot Ulcer
- +81 ;;^UTILITY(U,$J,358.3,12429,1,4,0)
- +82 ;;=4^E11.621
- +83 ;;^UTILITY(U,$J,358.3,12429,2)
- +84 ;;=^5002656
- +85 ;;^UTILITY(U,$J,358.3,12430,0)
- +86 ;;=E11.641^^49^600^17
- +87 ;;^UTILITY(U,$J,358.3,12430,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,12430,1,3,0)
- +90 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
- +91 ;;^UTILITY(U,$J,358.3,12430,1,4,0)
- +92 ;;=4^E11.641
- +93 ;;^UTILITY(U,$J,358.3,12430,2)
- +94 ;;=^5002661
- +95 ;;^UTILITY(U,$J,358.3,12431,0)
- +96 ;;=E11.649^^49^600^18
- +97 ;;^UTILITY(U,$J,358.3,12431,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,12431,1,3,0)
- +100 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
- +101 ;;^UTILITY(U,$J,358.3,12431,1,4,0)
- +102 ;;=4^E11.649
- +103 ;;^UTILITY(U,$J,358.3,12431,2)
- +104 ;;=^5002662
- +105 ;;^UTILITY(U,$J,358.3,12432,0)
- +106 ;;=E78.01^^49^600^24
- +107 ;;^UTILITY(U,$J,358.3,12432,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,12432,1,3,0)
- +110 ;;=3^Familial Hypercholesterolemia
- +111 ;;^UTILITY(U,$J,358.3,12432,1,4,0)
- +112 ;;=4^E78.01
- +113 ;;^UTILITY(U,$J,358.3,12432,2)
- +114 ;;=^7570555
- +115 ;;^UTILITY(U,$J,358.3,12433,0)
- +116 ;;=E78.00^^49^600^33
- +117 ;;^UTILITY(U,$J,358.3,12433,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,12433,1,3,0)
- +120 ;;=3^Pure Hypercholesterolemia,Unspec
